Access
To read this story in full you will need to login or make a payment (see right).
News and Views
Nature 451, 21-22 (3 January 2008) | doi:10.1038/451021a; Published online 2 January 2008
nature jobs
Chief Scientific Manager - Medicinal Chemistry
- Syngene International
- Bangalore, Karnataka 560099 India
Senior Research Assistant / Laboratory Manager – Team 27 - Ref: 80469
- Wellcome Trust Sanger Institute
- Hinxton Cambridge CB10 1SA UK
Down's syndrome: Paradox of a tumour repressor
David W. Threadgill1
Abstract
Having three copies of chromosome 21 reduces the incidence of solid tumours in people with Down's syndrome. Studies in mice provide clues to why, and highlight a complex gene–function relationship.
Correlative epidemiological studies are powerful analytical tools that can provide insight into human health and disease. A case in point is the proposition1 that the age-adjusted incidence of solid tumours is lower in individuals with Down's syndrome than in the general population.
- David W. Threadgill is in the Department of Genetics, University of North Carolina at Chapel Hill, North Carolina 27599, USA.
Email: dwt@med.unc.edu
To read this story in full you will need to login or make a payment (see right).
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
RESEARCH
Trisomy represses Apc Min -mediated tumours in mouse models of Down?s syndromeNature Letters to Editor (03 Jan 2008)

